These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 7519142

  • 1. Quantitative topographical EEG compared to FDG PET for classification of vascular and degenerative dementia.
    Szelies B, Mielke R, Herholz K, Heiss WD.
    Electroencephalogr Clin Neurophysiol; 1994 Aug; 91(2):131-9. PubMed ID: 7519142
    [Abstract] [Full Text] [Related]

  • 2. HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern.
    Mielke R, Pietrzyk U, Jacobs A, Fink GR, Ichimiya A, Kessler J, Herholz K, Heiss WD.
    Eur J Nucl Med; 1994 Oct; 21(10):1052-60. PubMed ID: 7828614
    [Abstract] [Full Text] [Related]

  • 3. Quantitative EEG mapping and PET in Alzheimer's disease.
    Szelies B, Grond M, Herholz K, Kessler J, Wullen T, Heiss WD.
    J Neurol Sci; 1992 Jul; 110(1-2):46-56. PubMed ID: 1506868
    [Abstract] [Full Text] [Related]

  • 4. FDG PET and differential diagnosis of dementia.
    Herholz K.
    Alzheimer Dis Assoc Disord; 1995 Jul; 9(1):6-16. PubMed ID: 7605624
    [Abstract] [Full Text] [Related]

  • 5. Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type.
    Mielke R, Herholz K, Grond M, Kessler J, Heiss WD.
    Neurobiol Aging; 1992 Jul; 13(1):93-8. PubMed ID: 1542386
    [Abstract] [Full Text] [Related]

  • 6. FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease.
    Mosconi L, Mistur R, Switalski R, Tsui WH, Glodzik L, Li Y, Pirraglia E, De Santi S, Reisberg B, Wisniewski T, de Leon MJ.
    Eur J Nucl Med Mol Imaging; 2009 May; 36(5):811-22. PubMed ID: 19142633
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Positron emission tomography in Alzheimer's disease.
    Duara R, Grady C, Haxby J, Sundaram M, Cutler NR, Heston L, Moore A, Schlageter N, Larson S, Rapoport SI.
    Neurology; 1986 Jul; 36(7):879-87. PubMed ID: 3487046
    [Abstract] [Full Text] [Related]

  • 9. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM.
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [Abstract] [Full Text] [Related]

  • 10. EEG delta, positron emission tomography, and memory deficit in Alzheimer's disease.
    Valladares-Neto DC, Buchsbaum MS, Evans WJ, Nguyen D, Nguyen P, Siegel BV, Stanley J, Starr A, Guich S, Rice D.
    Neuropsychobiology; 1995 May; 31(4):173-81. PubMed ID: 7659198
    [Abstract] [Full Text] [Related]

  • 11. EEG power changes are related to regional cerebral glucose metabolism in vascular dementia.
    Szelies B, Mielke R, Kessler J, Heiss WD.
    Clin Neurophysiol; 1999 Apr; 110(4):615-20. PubMed ID: 10378729
    [Abstract] [Full Text] [Related]

  • 12. Positron emission tomography for diagnosis of Alzheimer's disease and vascular dementia.
    Mielke R, Heiss WD.
    J Neural Transm Suppl; 1998 Apr; 53():237-50. PubMed ID: 9700661
    [Abstract] [Full Text] [Related]

  • 13. High-resolution PET studies in Alzheimer's disease.
    Kumar A, Schapiro MB, Grady C, Haxby JV, Wagner E, Salerno JA, Friedland RP, Rapoport SI.
    Neuropsychopharmacology; 1991 Jan; 4(1):35-46. PubMed ID: 2003867
    [Abstract] [Full Text] [Related]

  • 14. Cerebral metabolic response to passive audiovisual stimulation in patients with Alzheimer's disease and healthy volunteers assessed by PET.
    Pietrini P, Alexander GE, Furey ML, Dani A, Mentis MJ, Horwitz B, Guazzelli M, Shapiro MB, Rapoport SI.
    J Nucl Med; 2000 Apr; 41(4):575-83. PubMed ID: 10768555
    [Abstract] [Full Text] [Related]

  • 15. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.
    Piert M, Koeppe RA, Giordani B, Berent S, Kuhl DE.
    J Nucl Med; 1996 Feb; 37(2):201-8. PubMed ID: 8667045
    [Abstract] [Full Text] [Related]

  • 16. Abnormalities of energy metabolism in Alzheimer's disease studied with PET.
    Heiss WD, Szelies B, Kessler J, Herholz K.
    Ann N Y Acad Sci; 1991 Feb; 640():65-71. PubMed ID: 1776760
    [Abstract] [Full Text] [Related]

  • 17. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
    Vander Borght T, Minoshima S, Giordani B, Foster NL, Frey KA, Berent S, Albin RL, Koeppe RA, Kuhl DE.
    J Nucl Med; 1997 May; 38(5):797-802. PubMed ID: 9170449
    [Abstract] [Full Text] [Related]

  • 18. Cerebral metabolism, anatomy, and cognition in monozygotic twins discordant for dementia of the Alzheimer type.
    Luxenberg JS, May C, Haxby JV, Grady C, Moore A, Berg G, White BJ, Robinette D, Rapoport SI.
    J Neurol Neurosurg Psychiatry; 1987 Mar; 50(3):333-40. PubMed ID: 3494105
    [Abstract] [Full Text] [Related]

  • 19. [Comparison of SPECT and quantified EEG features in Alzheimer's type dementia].
    Gueguen B, Ancri D, Derouesné C, Bourdel MC, Guillou S, Landre E.
    Neurophysiol Clin; 1991 Dec; 21(5-6):377-87. PubMed ID: 1808497
    [Abstract] [Full Text] [Related]

  • 20. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.
    Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE.
    J Nucl Med; 1995 Jul; 36(7):1238-48. PubMed ID: 7790950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.